10x Genomics (TXG) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $72.39, -0.97% vs the prior close of $73.10.
- Volume 4.32M shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TXG dips 1.0% to $72.39. Closed at $72.39, -0.97% vs the prior close of $73.10. Day range $68.57–$73.74, opened at $69.35.
TXG daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — TXG dips 1.0% to $72.39
- Closed at $72.39, -0.97% vs the prior close of $73.10. Day range $68.57–$73.74, opened at $69.35.
- Volume was 4.32M shares, 1.2x its 50-day average of 3.47M.
- Price is +2.8% vs its 50-day average ($70.41) and +92.8% vs its 200-day average ($37.54).
- 52-week range $11.62–$102.81; today's close sits at 67% of that range, 29.6% below the 52-week high.
Oct 14, 2026 — TXG rises 1.8% to $73.10
- Closed at $73.10, +1.82% vs the prior close of $71.79. Day range $68.45–$74.33, opened at $69.52.
- Volume was 4.14M shares, 1.2x its 50-day average of 3.44M.
- Price is +4.6% vs its 50-day average ($69.91) and +96.2% vs its 200-day average ($37.26).
- 52-week range $11.16–$102.81; today's close sits at 68% of that range, 28.9% below the 52-week high.
Oct 13, 2026 — TXG slides 4.5% to $71.79
- Closed at $71.79, -4.52% vs the prior close of $75.19. Day range $71.25–$74.55, opened at $74.50.
- Volume was 4.04M shares, 1.2x its 50-day average of 3.43M.
- Price is +3.4% vs its 50-day average ($69.41) and +94.1% vs its 200-day average ($36.98).
- 52-week range $11.16–$102.81; today's close sits at 66% of that range, 30.2% below the 52-week high.
Oct 12, 2026 — TXG slides 6.8% to $75.19
- Closed at $75.19, -6.77% vs the prior close of $80.65. Day range $71.61–$80.47, opened at $79.18.
- Volume was 4.08M shares, 1.2x its 50-day average of 3.41M.
- Price is +9.1% vs its 50-day average ($68.91) and +104.9% vs its 200-day average ($36.70).
- 52-week range $11.16–$102.81; today's close sits at 70% of that range, 26.9% below the 52-week high.
Oct 9, 2026 — TXG jumps 4.4% to $80.65
- Closed at $80.65, +4.36% vs the prior close of $77.28. Day range $78.52–$85.12, opened at $78.60.
- Volume was 3.69M shares, 1.1x its 50-day average of 3.38M.
- Price is +18.0% vs its 50-day average ($68.35) and +121.5% vs its 200-day average ($36.41).
- 52-week range $11.16–$102.81; today's close sits at 76% of that range, 21.6% below the 52-week high.
Oct 8, 2026 — TXG rises 1.6% to $77.28
- Closed at $77.28, +1.55% vs the prior close of $76.10. Day range $70.94–$77.58, opened at $73.50.
- Volume was 5.70M shares, 1.7x its 50-day average of 3.31M.
- Price is +14.1% vs its 50-day average ($67.73) and +114.1% vs its 200-day average ($36.09).
- 52-week range $11.16–$102.81; today's close sits at 72% of that range, 24.8% below the 52-week high.
Oct 7, 2026 — TXG slides 5.7% to $76.10 on 3.0x normal volume
- Closed at $76.10, -5.65% vs the prior close of $80.66. Day range $73.00–$82.72, opened at $77.52.
- Volume was 9.37M shares, 3.0x its 50-day average of 3.18M — unusually heavy trading.
- Price is +13.4% vs its 50-day average ($67.11) and +112.7% vs its 200-day average ($35.78).
- 52-week range $11.16–$102.81; today's close sits at 71% of that range, 26.0% below the 52-week high.
Oct 6, 2026 — TXG slides 17.5% to $80.66 on 3.0x normal volume
- Closed at $80.66, -17.47% vs the prior close of $97.74. Day range $79.90–$102.81, opened at $100.33.
- Volume was 9.06M shares, 3.0x its 50-day average of 3.04M — unusually heavy trading.
- Price is +21.2% vs its 50-day average ($66.53) and +127.3% vs its 200-day average ($35.48).
- 52-week range $11.16–$102.81; today's close sits at 76% of that range, 21.5% below the 52-week high.
Oct 5, 2026 — TXG jumps 4.5% to $97.74, a 52-week high
- Closed at $97.74, +4.53% vs the prior close of $93.50. Day range $92.26–$98.32, opened at $93.50.
- Volume was 3.10M shares, 1.0x its 50-day average of 3.03M.
- Price is +48.5% vs its 50-day average ($65.83) and +178.0% vs its 200-day average ($35.16).
- 52-week range $11.16–$98.32; today's close sits at 99% of that range, 0.6% below the 52-week high.
Oct 2, 2026 — TXG jumps 5.3% to $93.50, a 52-week high
- Closed at $93.50, +5.34% vs the prior close of $88.76. Day range $88.14–$94.56, opened at $90.04.
- Volume was 3.14M shares, 1.0x its 50-day average of 3.03M.
- Price is +44.3% vs its 50-day average ($64.80) and +169.1% vs its 200-day average ($34.75).
- 52-week range $11.16–$95.16; today's close sits at 98% of that range, 1.7% below the 52-week high.
TXG latest news & SEC filings
Every SEC filing by or about TXG in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 24, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Suliman Shehnaaz sold 292 shares at $78.20 (≈$22.83K) on Sep 22, 2026; now holds 29,223
- Suliman Shehnaaz sold 614 shares at $79.51 (≈$48.82K) on Sep 22, 2026; now holds 28,609
- Suliman Shehnaaz sold 1,325 shares at $80.82 (≈$107.08K) on Sep 22, 2026; now holds 27,284
- Suliman Shehnaaz sold 2,270 shares at $81.67 (≈$185.39K) on Sep 22, 2026; now holds 25,014
- Suliman Shehnaaz sold 1,222 shares at $82.28 (≈$100.54K) on Sep 22, 2026; now holds 23,792
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Saxonov Serge sold 1,000 shares at $78.23 (≈$78.23K) on Sep 22, 2026; now holds 1,074,249
- Saxonov Serge sold 2,000 shares at $79.62 (≈$159.24K) on Sep 22, 2026; now holds 1,072,249
- Saxonov Serge sold 9,300 shares at $80.90 (≈$752.40K) on Sep 22, 2026; now holds 1,062,949
- Saxonov Serge sold 9,900 shares at $81.83 (≈$810.07K) on Sep 22, 2026; now holds 1,053,049
- Saxonov Serge sold 2,800 shares at $82.36 (≈$230.62K) on Sep 22, 2026; now holds 1,050,249
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 11, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Taich Adam sold 1,206 shares at $63.68 (≈$76.80K) on Sep 9, 2026
- Taich Adam sold 13,754 shares at $65.26 (≈$897.59K) on Sep 9, 2026
- Taich Adam sold 31,428 shares at $64.31 (≈$2.02M) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 9, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 8, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Stuelpnagel John R sold 6,814 shares at $62.11 (≈$423.22K) on Sep 3, 2026
- Stuelpnagel John R sold 7,012 shares at $60.66 (≈$425.35K) on Sep 3, 2026
- Stuelpnagel John R sold 6,174 shares at $62.61 (≈$386.55K) on Sep 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $151.04M (prior year $172.91M) (-12.6% vs Jun 30, 2025)
- Net income: -$17.93M (prior year $34.54M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.14 (prior year $0.28) (loss widened vs Jun 30, 2025)
Aug 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade TXG
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 12, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.27% (largest 17.5%). That is a volatile stock.
- Liquidity: about 4.23M shares (≈$306.29M) trade per day on average.
- 52-week position: $72.39 vs a range of $11.62–$102.81 (67% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Serge Saxonov sold 1,000 shares on Sep 22, 2026.
- Latest filings: 10-Q Aug 7, 2026; 8-K Aug 6, 2026; 8-K Jun 8, 2026.
- Listing: Nasdaq · industry: Laboratory Analytical Instruments.
TXG market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 69.35 | 73.74 | 68.57 | 72.39 | 4.32M |
| Oct 14, 2026 | 69.52 | 74.33 | 68.45 | 73.10 | 4.14M |
| Oct 13, 2026 | 74.50 | 74.55 | 71.25 | 71.79 | 4.04M |
| Oct 12, 2026 | 79.18 | 80.47 | 71.61 | 75.19 | 4.08M |
| Oct 9, 2026 | 78.60 | 85.12 | 78.52 | 80.65 | 3.69M |
| Oct 8, 2026 | 73.50 | 77.58 | 70.94 | 77.28 | 5.70M |
| Oct 7, 2026 | 77.52 | 82.72 | 73.00 | 76.10 | 9.37M |
| Oct 6, 2026 | 100.33 | 102.81 | 79.90 | 80.66 | 9.06M |
| Oct 5, 2026 | 93.50 | 98.32 | 92.26 | 97.74 | 3.10M |
| Oct 2, 2026 | 90.04 | 94.56 | 88.14 | 93.50 | 3.14M |
| Oct 1, 2026 | 89.30 | 92.92 | 86.75 | 88.76 | 3.25M |
| Sep 30, 2026 | 92.30 | 95.16 | 90.23 | 90.36 | 3.75M |
| Sep 29, 2026 | 89.24 | 91.99 | 87.29 | 90.04 | 3.45M |
| Sep 28, 2026 | 86.00 | 89.95 | 84.27 | 88.50 | 3.37M |
| Sep 25, 2026 | 83.76 | 86.16 | 80.72 | 85.71 | 3.39M |
| Sep 24, 2026 | 75.50 | 85.93 | 74.60 | 84.11 | 4.09M |
| Sep 23, 2026 | 80.37 | 81.93 | 74.75 | 75.62 | 3.47M |
| Sep 22, 2026 | 79.42 | 82.68 | 77.50 | 80.70 | 3.89M |
| Sep 21, 2026 | 79.15 | 80.11 | 76.73 | 79.10 | 2.45M |
| Sep 18, 2026 | 77.64 | 78.08 | 75.21 | 76.60 | 2.88M |
About 10x Genomics
10x Genomics (TXG) is listed on the Nasdaq and classified by the SEC under “Laboratory Analytical Instruments”. Its business address is in PLEASANTON, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1770787.
TXG board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Benjamin J. Hindson | See Remarks | Aug 26, 2026 |
| Sridhar Kosaraju | Director | Jun 8, 2026 |
| Alan Mateo | Director | Jun 8, 2026 |
| Kimberly J Popovits | Director | Jun 8, 2026 |
| John R Stuelpnagel | Director | Sep 8, 2026 |
| Shehnaaz Suliman | Director | Sep 24, 2026 |
| Serge Saxonov | Chief Executive Officer | Sep 24, 2026 |
| Sarah A. Teichmann | Director | Aug 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Benjamin J. Hindson | See Remarks | Aug 26, 2026 |
| Serge Saxonov | Chief Executive Officer | Sep 24, 2026 |
| Adam Taich | Chief Financial Officer | Sep 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 22, 2026 | Serge Saxonov | Sale | 1,000 | $78.23 |
| Sep 22, 2026 | Serge Saxonov | Sale | 9,900 | $81.83 |
| Sep 22, 2026 | Serge Saxonov | Sale | 9,300 | $80.90 |
| Sep 22, 2026 | Serge Saxonov | Sale | 2,000 | $79.62 |
| Sep 22, 2026 | Serge Saxonov | Sale | 2,800 | $82.37 |
| Sep 22, 2026 | Shehnaaz Suliman | Sale | 1,325 | $80.82 |
| Sep 22, 2026 | Shehnaaz Suliman | Sale | 2,270 | $81.67 |
| Sep 22, 2026 | Shehnaaz Suliman | Sale | 292 | $78.20 |
| Sep 22, 2026 | Shehnaaz Suliman | Sale | 614 | $79.51 |
| Sep 22, 2026 | Shehnaaz Suliman | Sale | 1,222 | $82.28 |
| Sep 9, 2026 | Adam Taich | Sale | 1,206 | $63.68 |
| Sep 9, 2026 | Adam Taich | Sale | 13,754 | $65.26 |
| Sep 9, 2026 | Adam Taich | Sale | 31,428 | $64.31 |
| Sep 3, 2026 | John R Stuelpnagel | Sale | 6,814 | $62.11 |
| Sep 3, 2026 | John R Stuelpnagel | Sale | 7,012 | $60.66 |
TXG financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $642.82M | $-43.54M | -0.35 | $136.05M |
| Dec 31, 2024 | $610.78M | $-182.63M | -1.52 | $6.66M |
| Dec 31, 2023 | $618.73M | $-255.10M | -2.18 | $-15.20M |
| Dec 31, 2022 | $516.41M | $-166.00M | -1.46 | $-33.61M |
| Dec 31, 2021 | $490.49M | $-58.22M | -0.53 | $-21.37M |
Latest balance sheet: total assets $1.03B, total liabilities $204.52M, cash $344.07M (as of Jun 30, 2026).
TXG earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $45.60 |
| May 7, 2026 | 8-K Item 2.02 (results) | $22.42 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $17.51 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $19.80 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $13.00 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $12.80 |
| May 8, 2025 | 8-K Item 2.02 (results) | $8.63 |
| Feb 12, 2025 | 8-K Item 2.02 (results) | $12.00 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $15.71 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $15.79 |
| Oct 9, 2024 | 8-K Item 2.02 (results) | — |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Laboratory Analytical Instruments
Illumina (ILMN)Waters (WAT)Mettler Toledo International Inc/ (MTD)Revvity (RVTY)Agilent Technologies (A)Bruker (BRKR)Avantor (AVTR)Bio-Rad Laboratories (BIO)Alamar Biosciences (ALMR)Pacific Biosciences Of California (PACB)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on TXG
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.